Tumor mutational load predicts survival after immunotherapy across multiple cancer typesRobert Samstein, Ronald P. DeMatteo, Chung‐Han Lee et al.|Nature Genetics|2019Cited by 4.4k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase InhibitorsIngo K. Mellinghoff, Paul S. Mischel, Maria Y. Wang et al.|New England Journal of Medicine|2005Cited by 1.4k
Glioblastoma and Other Primary Brain Malignancies in AdultsLauren Schaff, Ingo K. Mellinghoff|JAMA|2023Cited by 1.1k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y. Wen, Martin J. van den Bent, Minesh P. Mehta et al.|Neuro-Oncology|2020Cited by 1.1k
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to gliomaRameen Beroukhim, William R. Sellers, Gad Getz et al.|Proceedings of the National Academy of Sciences|2007Cited by 1.1k